HALOZYME THERAPEUTICS INC. - Daily - Technical analysis published on 01/15/2021 (GMT)
- 227
- 0
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : TARGET REACHED
Summary of the analysis
Additional analysis
Quotes
The HALOZYME THERAPEUTICS INC. rating is 46.98 USD. On the day, this instrument lost -0.15% and was traded between 46.58 USD and 48.35 USD over the period. The price is currently at +0.86% from its lowest and -2.83% from its highest.The Central Gaps scanner detects the formation of a bullish gap marking the strong presence of buyers against sellers at the opening. This formed a quotation gap.
Opening Gap UP
Type : Bullish
Timeframe : Openning
A study of price movements over other periods shows the following variations:
New HIGH record (5 years)
Type : Bullish
Timeframe : Weekly
New HIGH record (1 year)
Type : Bullish
Timeframe : Weekly
New HIGH record (1st january)
Type : Bullish
Timeframe : Weekly
New HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
Technical
Technical analysis of this Daily chart of HALOZYME THERAPEUTICS INC. indicates that the overall trend is strongly bullish. 92.86% of the signals given by moving averages are bullish. The overall trend is supported by the strong bullish signals from short-term moving averages. The Central Indicators scanner does not detect any result on moving averages that would impact this trend.
In fact, 15 technical indicators on 18 studied are currently positioned bullish. But beware of excesses. The Central Indicators scanner currently detects this:
CCI indicator is overbought : over 100
Type : Neutral
Timeframe : Daily
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : Daily
Pivot points : price is over resistance 1
Type : Neutral
Timeframe : Weekly
MACD crosses UP its Moving Average
Type : Bullish
Timeframe : Daily
Price is back over the pivot point
Type : Bullish
Timeframe : Daily
An analysis of the price chart with the Central Patterns scanner (detector of chart patterns and resistances and supports) shows a result that can have an impact on the price change:
Support of channel is broken
Type : Bearish
Timeframe : Daily
No result was found by the Central Candlesticks scanner on Japanese candlesticks.
S3 | S2 | S1 | Price | |
---|---|---|---|---|
ProTrendLines | 24.75 | 29.63 | 41.93 | 46.98 |
Change (%) | -47.32% | -36.93% | -10.75% | - |
Change | -22.23 | -17.35 | -5.05 | - |
Level | Major | Major | Intermediate | - |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 43.63 | 44.49 | 45.77 | 46.63 | 47.91 | 48.77 | 50.05 |
Camarilla | 46.46 | 46.66 | 46.85 | 47.05 | 47.25 | 47.44 | 47.64 |
Woodie | 43.84 | 44.60 | 45.98 | 46.74 | 48.12 | 48.88 | 50.26 |
Fibonacci | 44.49 | 45.31 | 45.81 | 46.63 | 47.45 | 47.95 | 48.77 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 37.02 | 39.20 | 41.39 | 43.57 | 45.76 | 47.94 | 50.13 |
Camarilla | 42.37 | 42.77 | 43.17 | 43.57 | 43.97 | 44.37 | 44.77 |
Woodie | 37.02 | 39.20 | 41.39 | 43.57 | 45.76 | 47.94 | 50.13 |
Fibonacci | 39.20 | 40.87 | 41.90 | 43.57 | 45.24 | 46.27 | 47.94 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 34.03 | 36.50 | 39.60 | 42.07 | 45.17 | 47.64 | 50.74 |
Camarilla | 41.18 | 41.69 | 42.20 | 42.71 | 43.22 | 43.73 | 44.24 |
Woodie | 34.36 | 36.66 | 39.93 | 42.23 | 45.50 | 47.80 | 51.07 |
Fibonacci | 36.50 | 38.62 | 39.94 | 42.07 | 44.19 | 45.51 | 47.64 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
RSI (14): | 69.17 | |
MACD (12,26,9): | 1.4800 | |
Directional Movement: | 18.66 | |
AROON (14): | 28.57 | |
DEMA (21): | 45.47 | |
Parabolic SAR (0,02-0,02-0,2): | 41.38 | |
Elder Ray (13): | 3.25 | |
Super Trend (3,10): | 41.57 | |
Zig ZAG (10): | 47.26 | |
VORTEX (21): | 1.1200 | |
Stochastique (14,3,5): | 83.76 | |
TEMA (21): | 45.36 | |
Williams %R (14): | -19.74 | |
Chande Momentum Oscillator (20): | 4.87 | |
Repulse (5,40,3): | 2.8700 | |
ROCnROLL: | 1 | |
TRIX (15,9): | 0.4100 | |
Courbe Coppock: | 10.67 |
MA7: | 44.86 | |
MA20: | 43.47 | |
MA50: | 41.04 | |
MA100: | 34.55 | |
MAexp7: | 45.22 | |
MAexp20: | 43.56 | |
MAexp50: | 40.45 | |
MAexp100: | 36.38 | |
Price / MA7: | +4.73% | |
Price / MA20: | +8.07% | |
Price / MA50: | +14.47% | |
Price / MA100: | +35.98% | |
Price / MAexp7: | +3.89% | |
Price / MAexp20: | +7.85% | |
Price / MAexp50: | +16.14% | |
Price / MAexp100: | +29.14% |
News
Don"t forget to follow the news on HALOZYME THERAPEUTICS INC.. At the time of publication of this analysis, the latest news was as follows:
- Halozyme To Present Virtually At The 39th Annual J.P. Morgan Healthcare Conference
- Halozyme To Participate In Fireside Chat For The Piper Sandler 32nd Annual Virtual Healthcare Conference
- Thinking about trading options or stock in Ford, Draftkings, Li Auto, Vipshop Holdings, or Halozyme Therapeutics?
- MGIC Investment & Halozyme Therapeutics Set to Join S&P MidCap 400; First Bancorp, The Geo Group & Mednax to Join S&P SmallCap 600
- Halozyme Announces Upcoming Data Presentations at American Society of Hematology Annual Meeting For APOLLO and ANDROMEDA Phase 3 Studies By Janssen Evaluating Subcutaneous Daratumumab Utilizing ENHANZE®
Add a comment
Comments
0 comments on the analysis HALOZYME THERAPEUTICS INC. - Daily